GE to supply sequencing technology for breast cancer research

09/29/2013 | Genetic Engineering & Biotechnology News

Researchers at Karolinska Institutet in Europe will use GE Healthcare's sequencing technology to detect alleles and mutations linked to metastatic breast cancer. The deal, whose terms were not disclosed, is part of GE's initiative to invest in the development of novel molecular imaging and cancer diagnostic capabilities. The company is also investing in biopharmaceutical manufacturing.

View Full Article in:

Genetic Engineering & Biotechnology News

Published in Briefs:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Senior Legal Counsel
Alcon
Fort Worth, TX
Senior Scientist - Cell Engineering Group
Pfizer
San Francisco, CA
Associate Director, Compliance Business Partner I
Boehringer Ingelheim
Ridgefield, CT
Attorney
U.S. DEPARTMENT OF HEALTH & HUMAN SERVICES Food and Drug Administration Office of the Chief Counsel
Silver Spring, MD, MD
Counsel – Regulatory Affairs
RAI Services Company
Winston Salem, NC